Cerus (CERS) Competitor Comparison
We are evaluating the key criteria listed to compare Cerus (CERS) against its competitors in the Biotechnology industry.
Market Capitalization
179 / 368Gross Profits
48 / 278Total Revenue
72 / 300EBITDA
118 / 337Free Cashflow
102 / 352Quick Ratio
317 / 357Earnings per Share
49 / 359Dividend yield
0 / 6Total Cash
233 / 358Performance 3 years
231 / 368Performance 5 years
186 / 368Performance 10 years
187 / 368Linearity 3 years
187 / 368Linearity 5 years
105 / 368Linearity 10 years
126 / 367Total Rank
22 / 368Dividend Rank
86 / 368Valuation Rank
106 / 368Piotroski Rank
62 / 368Muliplier Rank
97 / 368Market Capitalization - CERS ranking 179 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.